- Home
- WXM vs MIRA Comparison
WXM vs MIRA Comparison
Compare WXM & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WXM
- MIRA
- Stock Information
- Founded
- WXM 2009
- MIRA 2020
- Country
- WXM China
- MIRA United States
- Employees
- WXM N/A
- MIRA N/A
- Industry
- WXM
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- WXM
- MIRA Health Care
- Exchange
- WXM NYSE
- MIRA Nasdaq
- Market Cap
- WXM 18.9M
- MIRA 19.5M
- IPO Year
- WXM 2025
- MIRA 2023
- Fundamental
- Price
- WXM $3.75
- MIRA $1.66
- Analyst Decision
- WXM
- MIRA Strong Buy
- Analyst Count
- WXM 0
- MIRA 2
- Target Price
- WXM N/A
- MIRA $14.00
- AVG Volume (30 Days)
- WXM 159.3K
- MIRA 3.1M
- Earning Date
- WXM 01-01-0001
- MIRA 08-12-2025
- Dividend Yield
- WXM N/A
- MIRA N/A
- EPS Growth
- WXM 67.61
- MIRA N/A
- EPS
- WXM 0.18
- MIRA N/A
- Revenue
- WXM $15,524,259.00
- MIRA N/A
- Revenue This Year
- WXM N/A
- MIRA N/A
- Revenue Next Year
- WXM N/A
- MIRA N/A
- P/E Ratio
- WXM $21.19
- MIRA N/A
- Revenue Growth
- WXM 10.86
- MIRA N/A
- 52 Week Low
- WXM $1.52
- MIRA $0.62
- 52 Week High
- WXM $7.99
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- WXM N/A
- MIRA 73.89
- Support Level
- WXM N/A
- MIRA $1.07
- Resistance Level
- WXM N/A
- MIRA $1.39
- Average True Range (ATR)
- WXM 0.00
- MIRA 0.14
- MACD
- WXM 0.00
- MIRA 0.04
- Stochastic Oscillator
- WXM 0.00
- MIRA 90.77
About WXM WF INTERNATIONAL LIMITED
WF International Ltd is engaged in the provision of supply, installation, fitting-out and maintenance services for HVAC system and floor heating systems. It provides the supply, installation and fitting-out services for HVAC systems for large-scaled commercial projects consisting of offices, hotels, manufactures, airports and hospitals, such as the International Finance Square HVAC projects across China, Chengdu Vanke Charm City, Chengdu Raffles Plaza, Chengdu Yinshi Plaza, Chengdu Metro No. Ten Line, and Panzhihua Jinhai Hotel.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.